Back to today’s briefing

Story perspectives

Targeting Metabolism: New Insights in Pancreatic Cancer Treatment

10/5/2025

27 4

Summary

Story summary

Growing evidence shows the tumor microenvironment shapes pancreatic cancer treatment outcomes across patients.
Targeting metabolic pathways like glycolysis may boost therapy efficacy.
The ALDOA gene is a potential target influencing proliferation and chemoresistance.
The glycan CA19-9 may promote pancreatitis and pancreatic cancer.
Research links inflammation, metabolism, and immune responses in pancreatic cancer progression.

1 of 1

Story summary

Growing evidence shows the tumor microenvironment shapes pancreatic cancer treatment outcomes across patients.
Targeting metabolic pathways like glycolysis may boost therapy efficacy.
The ALDOA gene is a potential target influencing proliferation and chemoresistance.
The glycan CA19-9 may promote pancreatitis and pancreatic cancer.
Research links inflammation, metabolism, and immune responses in pancreatic cancer progression.